Rare cancers - 9/11 Victim Compensation Fund claims

Increased rare cancer risk among 9/11 survivors and responders

According to the World Trade Center Health Program, a rare cancer is defined as a cancer that affects fewer than 15 people per 100,000 annually in the U.S. Tragically, many 9/11 survivors and responders are being diagnosed with these rare cancers at alarming rates.

While this isn't an exhaustive list, the following rare cancers are recognized by the WTCHP as being linked to 9/11 exposure:

• neuroendocrine malignancies
• male breast cancer
• gallbladder and biliary tract cancer
• small intestine cancer
• thymus cancer
• central nervous system cancer
• adrenal gland cancer
• penile cancer
• gastrointestinal stromal tumors 

9/11 Victim Compensation Fund payout for rare cancer

If you were at the 9/11 attack site during or after the attacks and have since developed a rare cancer, you may be eligible for compensation. The VCF calculates your potential payouts based on your non-economic losses (like pain and suffering) and economic losses (like lost wages). They'll also factor in any other compensation you've received for your injuries.

While the VCF provides up to $250,000, the amount can be higher based on the severity.